Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Hein

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|July 23, 2021
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trialDavid Cibula, Lukas Rob, Peter Mallmann, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)Alexander Hein, Sven Kehl, Lothar Häberle, et al.
Human Molecular Genetics|February 14, 2022
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancerDhanya Ramachandran, Joe Dennis, Laura Fachal, et al.
Cell|August 29, 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapyHannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
International Journal of Cancer|June 25, 2020
Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levelsDhanya Ramachandran, Peter Schürmann, Qianqian Mao, et al.
Breast Cancer Research and Treatment|June 11, 2016
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patientsAlexander Hein, Paul Gass, Christina Barbara Walter, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|July 23, 2021
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trialDavid Cibula, Lukas Rob, Peter Mallmann, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)Alexander Hein, Sven Kehl, Lothar Häberle, et al.
Human Molecular Genetics|February 14, 2022
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancerDhanya Ramachandran, Joe Dennis, Laura Fachal, et al.
Cell|August 29, 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous RetrovirusesKatherine B Chiappinelli, Pamela L Strissel, Alexis Desrichard, et al.
Breast Care (Basel, Switzerland)|June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating LymphocytesFranziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer|June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapyHannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
International Journal of Cancer|June 25, 2020
Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levelsDhanya Ramachandran, Peter Schürmann, Qianqian Mao, et al.
Breast Cancer Research and Treatment|June 11, 2016
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patientsAlexander Hein, Paul Gass, Christina Barbara Walter, et al.
Breast Cancer Research and Treatment|November 21, 2022
Return of individual genomic research results within the PRAEGNANT multicenter registry studyHanna Huebner, Matthias Ruebner, Christian Kurbacher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 statusAlexander Hein, Andreas D Hartkopf, Julius Emons, et al.
Pageof 18